Ascletis

Ascletis

Ascletis

Raised
$520M
Follow us
Alexa global traffic share
Latest funding Show all
$400,000,000
IPO - 2018
$100,000,000
Venture capital (Series B) - 2017
Goldman Sachs Focus Media Tasly Pharmaceutical +3
Team Size
1–10
Employees
$400,000,000 IPO
PE HUB

Chinese biotech firm Ascletis raises $400 million in HK IPO, say sources: Reuters

Funding Health Asia
AVCJ

Chinese drug developer Ascletis files for landmark HK IPO

Funding
$20,000,000 Venture capital (Series C)
FinSMEs

Ascletis Receives US$20M Investment from Goldman Sachs